Risks and benefits of combined maze procedure for atrial fibrillation associated with organic heart disease.
OBJECTIVE
This study sought to identify the risks and benefits of adding the maze procedure in patients with atrial fibrillation (AF) undergoing operation for underlying organic cardiac disorders.


BACKGROUND
Persistent AF often leaves patients symptomatic even after otherwise successful cardiac surgery.


METHODS
Fifty-one patients undergoing valvular operation and the maze procedure (n = 43) or repair of congenital anomalies (n = 8) combined with the maze procedure were compared with 51 patients (control group) matched for underlying diseases and procedures except for the maze operation. Each group, including 31 patients with a concomitant tricuspid annuloplasty and 12 undergoing reoperation, were similar in age, duration of arrhythmia, degree of cardiomegaly and New York Heart Association functional class.


RESULTS
Patients undergoing the maze procedure had longer cardiopulmonary bypass time (213 vs. 144 min, p < 0.0001), longer cardiac arrest (134 vs. 93 min, p < 0.0001) and greater blood loss with longer respiratory care (39 vs. 18 h p = 0.021) and intensive care unit stay but no mortality. No significant differences were found in catecholamine or transfusion requirements immediately after operation. Sustained AF was much less frequent in the maze group (12% at 1 year) than the control group (86%, p < 0.0001), with an average follow-up period of 32 months (range 25 to 42). Atrial contraction was documented in 41 (80%) and 40 (78%) patients for right and left ventricular filling, respectively, after the maze procedure, resulting in a significantly smaller cardiac size and improved functional capacity. Medication was discontinued in seven patients in the maze group compared with two in the control group.


CONCLUSIONS
Improved restoration of atrial rhythm and contraction with combined maze operation appeared to justify the increased operative time and complexity and postoperative care.
Kawaguchi
A T
AT
National Cardiovascular Center, Suita, Osaka, Japan. akira@ri.ncvc.go.jp
Kosakai
Y
Y
Sasako
Y
Y
Eishi
K
K
Nakano
K
K
Kawashima
Y
Y
D001281:Atrial Fibrillation / Q000150:complications / Q000601:surgery*; D006348:Cardiac Surgical Procedures / Q000379:methods; D002315:Cardiopulmonary Bypass; D016022:Case-Control Studies; D006325:Heart Atria / Q000601:surgery; D006330:Heart Defects, Congenital / Q000150:complications; D006349:Heart Valve Diseases / Q000150:complications; D006801:Humans; D008875:Middle Aged; D011182:Postoperative Care; D012189:Retrospective Studies; D012307:Risk Factors